Yamashita, Alex Shimura; Baia, Gilson Soares; Ho, J. S. Y.; Velarde, E.; Wong, J.; Gallia, Gary L.; Belzberg, A. J.; Kimura, Edna Teruko 
; Riggins, Gregory J.
Fonte: Journal of Neuro-Oncology. Unidade: ICB
Assuntos: HISTOLOGIA, RADIOTERAPIA, SISTEMA NERVOSO PERIFÉRICO, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMASHITA, Alex Shimura et al. Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology, v. 118, n. 1, p. 83-92, 2014Tradução . . Disponível em: https://doi.org/10.1007/s11060-014-1422-5. Acesso em: 02 nov. 2024.APA
Yamashita, A. S., Baia, G. S., Ho, J. S. Y., Velarde, E., Wong, J., Gallia, G. L., et al. (2014). Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology, 118( 1), 83-92. doi:10.1007/s11060-014-1422-5NLM
Yamashita AS, Baia GS, Ho JSY, Velarde E, Wong J, Gallia GL, Belzberg AJ, Kimura ET, Riggins GJ. Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors [Internet]. Journal of Neuro-Oncology. 2014 ; 118( 1): 83-92.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s11060-014-1422-5Vancouver
Yamashita AS, Baia GS, Ho JSY, Velarde E, Wong J, Gallia GL, Belzberg AJ, Kimura ET, Riggins GJ. Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors [Internet]. Journal of Neuro-Oncology. 2014 ; 118( 1): 83-92.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s11060-014-1422-5
